This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Aug 28;349(9):829-30.

doi: 10.1056/NEJMp038124.

Cardiac-allograft vasculopathy

Robin K Avery¹

Affiliations

PMID: 12944567
DOI: 10.1056/NEJMp038124

Comment

Cardiac-allograft vasculopathy

Robin K Avery. N Engl J Med. 2003.

. 2003 Aug 28;349(9):829-30.

doi: 10.1056/NEJMp038124.

Author

Robin K Avery¹

Affiliation

¹ Department of Infectious Disease and Transplant Center, Cleveland Clinic Foundation, Cleveland, USA.

PMID: 12944567
DOI: 10.1056/NEJMp038124

No abstract available

PubMed Disclaimer

Comment on

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
Eisen HJ, Tuzcu EM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA, Starling RC, Sørensen K, Hummel M, Lind JM, Abeywickrama KH, Bernhardt P; RAD B253 Study Group. Eisen HJ, et al. N Engl J Med. 2003 Aug 28;349(9):847-58. doi: 10.1056/NEJMoa022171. N Engl J Med. 2003. PMID: 12944570 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information